News
WST
250.49
+2.82%
6.88
West Pharma Is Maintained at Equal-Weight by Barclays
Dow Jones · 10h ago
West Pharma Price Target Cut to $265.00/Share From $325.00 by Barclays
Dow Jones · 10h ago
Barclays Maintains Equal-Weight on West Pharmaceutical Servs, Lowers Price Target to $265
Benzinga · 10h ago
West Pharmaceutical price target lowered to $300 from $370 at BofA
TipRanks · 11h ago
West Pharmaceutical price target lowered to $340 from $355 at UBS
TipRanks · 13h ago
West Pharmaceutical price target raised to $315 from $310 at Deutsche Bank
TipRanks · 14h ago
West Pharmaceutical price target lowered to $265 from $325 at Barclays
TipRanks · 16h ago
West Pharmaceutical Services Margins Slip To 16.3% Raising Questions Around Bullish Growth Narratives
Simply Wall St · 1d ago
West Pharmaceutical Services Signals HVP‑Led Growth Ahead
TipRanks · 1d ago
West Pharmaceutical targets 5%–7% organic revenue growth for 2026 as HVP demand accelerates
Seeking Alpha · 1d ago
Buy Rating on West: Strong Non‑GLP‑1 Growth, Margin Expansion, and Regulatory Tailwinds Support 2026 Outlook
TipRanks · 1d ago
West Pharma (WST) Q4 2025 Earnings Call Transcript
The Motley Fool · 1d ago
West Pharmaceutical: Strong Quarterly Beat and Confident 2026 Outlook Support Buy Rating Despite GLP‑1 Concerns
TipRanks · 1d ago
West Pharmaceutical Services Posts Solid Q4 and 2025 Results
TipRanks · 1d ago
S&P 500 Futures Climb In Premarket Trading; Icon PLC, Baxter International Lag
Dow Jones · 1d ago
54 Stocks, 9 Megatrends: My Favorite Places To Be While Capital Is 'Forced'
Seeking Alpha · 1d ago
West Pharmaceutical Servs Sees FY2026 GAAP EPS $7.79-$8.14 vs $7.74 Est
Benzinga · 1d ago
West Pharmaceutical Servs Q4 Earnings Summary & Key Takeaways
Benzinga · 1d ago
West Pharmaceutical Q4 Earnings Rise; Guides FY26
NASDAQ · 1d ago
West Pharmaceutical sees Q1 adjusted EPS $1.65-$1.70, consensus $1.65
TipRanks · 1d ago
More
Webull provides a variety of real-time WST stock news. You can receive the latest news about West Pharm Svcs through multiple platforms. This information may help you make smarter investment decisions.
About WST
West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.